Sec Form 4 Filing - GENERAL ATLANTIC, L.P. @ CinCor Pharma, Inc. - 2022-01-11

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person GENERAL ATLANTIC, L.P. 2. Issuer Name and Ticker or Trading Symbol CinCor Pharma, Inc. [ CINC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O GENERAL ATLANTIC SERVICE CO.,L.P., 55 EAST 52ND STREET, 33RD FLOOR 3. Date of Earliest Transaction (MM/DD/YY) 01/11/2022 (Street) NEW YORK, NY10055 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.00001 per share ("Common Stock") 01/11/2022 C( 1 ) 2,426,470 A 2,426,470 I See footnote( 2 )( 3 )( 4 ) Common Stock 01/11/2022 P( 5 ) 1,700,000 A $ 16 4,126,470 I See footnote( 2 )( 3 )( 4 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series B Preferred Stock ( 1 ) 01/11/2022 C 8,250,000 ( 1 ) ( 1 ) Common Stock 2,426,470 ( 1 ) 0 I See footnote( 2 )( 3 )( 4 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other GENERAL ATLANTIC, L.P. C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X GENERAL ATLANTIC GENPAR, L.P. C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X General Atlantic Partners 100, L.P. C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X GAP COINVESTMENTS III, LLC C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X GAP COINVESTMENTS IV, LLC C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X GAP Coinvestments V, LLC C/O GENERAL ATLANTIC SERVICE CO.,L.P. 55 EAST 52ND STREET, 33RD FLOOR NEW YORK, NY10055 X General Atlantic Partners (Bermuda) EU, L.P. C/O CONYERS CLIENT SERVICES LIMITED CLARENDON HOUSE, 2 CHURCH STREET HAMILTON, D0HM 11 X General Atlantic Partners (Lux), SCSp 412F, ROUTE D'ESCH LUXEMBOURG, N4L-2086 X General Atlantic (Lux) S.a r.l. 412F, ROUTE D'ESCH LUXEMBOURG, N4L-2086 X General Atlantic GenPar (Lux) SCSp 412F, ROUTE D'ESCH LUXEMBOURG, N4L-2086 X Signatures /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Michael Gosk 01/13/2022 Signature of Reporting Person Date /s/ Ingrid van der Hoorn 01/13/2022 Signature of Reporting Person Date /s/ Ingrid van der Hoorn 01/13/2022 Signature of Reporting Person Date /s/ Ingrid van der Hoorn 01/13/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents the automatic conversion of Series B Preferred Stock into shares of Common Stock of CinCor Pharma, Inc. (" the Issuer"), on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering (the "IPO") which closed on January 11, 2022. ( 2 )Reflects securities held directly by General Atlantic (CIN), L.P. ("GA CIN"), a Delaware limited partnership. The limited partners of GA CIN are the following investment funds (the "GA Funds"): General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), General Atlantic Partners (Bermuda) EU, L.P., a Bermuda limited partnership ("GAP Bermuda EU"), General Atlantic Partners (Lux) SCSp, a Luxembourg special limited partnership ("GAP Lux"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V"). ( 3 )The general partner of GA (CIN) is General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"). The general partner of GAP Lux is General Atlantic GenPar, (Lux) SCSp, a Luxembourg special limited partnership ("GA GenPar Lux") and the general partner of GA GenPar Lux is General Atlantic (Lux) S.a.r.l., a Luxembourg company ("GA Lux"). The general partner of GAP Bermuda EU and the sole shareholder of GA Lux is General Atlantic GenPar (Bermuda), L.P., a Bermuda limited partnership ("GenPar Bermuda"). GAP (Bermuda) L.P. ("GAP (Bermuda) LP") is the general partner of GenPar Bermuda. ( 4 )The general partner of GAP 100 is General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"). General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). The members of the GA Management Committee are also the members of the management committee of GAP (Bermuda) LP. Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein. ( 5 )The shares of Common Stock were purchased by GA CIN in the Issuer's IPO which closed on January 11, 2022, at a price of $16.00.

Remarks: GA CIN, the GA Funds, GA SPV, GA GenPar Lux, GA Lux, GenPar Bermuda, GAP (Bermuda) LP, GA GenPar, and GA LP may be deemed to be members of a "group" for the purposes of the Securities Exchange Act of 1934. Each reporting person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by the reportin g person. This report shall not be deemed an admission that the reporting persons are a member of a group or the beneficial owner of any securities not directly owned by the reporting person. // Form 1 of 2.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.